Avantor, Inc. Segment Expenditure Addition To Long Lived Assets
Avantor, Inc. (AVTR) reported Segment Expenditure Addition To Long Lived Assets of $146.40 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-14.
Discontinued › Notes
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2024-02-14
- Avantor, Inc. segment expenditure addition to long lived assets for fiscal 2023 was $146.40M, a 9.75% increase from fiscal 2022.
- Avantor, Inc. segment expenditure addition to long lived assets for fiscal 2022 was $133.40M, a 20.07% increase from fiscal 2021.
- Avantor, Inc. segment expenditure addition to long lived assets for fiscal 2021 was $111.10M.
| Period end | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|
| 2023-12-31 | $146.40M 10-K · filed 2024-02-14 |
| 2022-12-31 | $133.40M 10-K · filed 2024-02-14 |
| 2021-12-31 | $111.10M 10-K · filed 2024-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |